Obesity News

An intervention involving an energy-reduced Mediterranean diet and physical activity promotion reduced total and visceral fat in adults with overweight or obesity and metabolic symptoms, according to a randomized study.

DALLAS — People with obesity who are prescribed anti-obesity medications may need to use the agents for life, but intermittent therapy can still confer health benefits, according to a speaker.

Although body mass index has long been used in clinical practice, many have recently questioned its effectiveness as a standalone measure for obesity.

DALLAS — Setmelanotide may lower the risk for metabolic syndrome for people with a rare monogenic form of obesity, according to data presented at ObesityWeek.

VANCOUVER, British Columbia — Glucagon-like peptide 1 agonists were significantly less effective for weight loss among patients who underwent laparoscopic sleeve gastrectomy and regained weight, according to a presenter.

VANCOUVER, British Columbia — Tirzepatide 15 mg was associated with the highest degree of weight loss compared with other glucagon-like peptide-1 agonists and placebo, according to a presenter at the ACG Annual Scientific Meeting.

Obesity was linked to an increased breast cancer recurrence risk among postmenopausal women with hormone receptor-positive early-stage breast cancer who were treated with aromatase inhibitors, researchers reported in JAMA Network Open.

DALLAS — Adults with obesity and a genetic mutation that causes deficiency in the melanocortin-4 receptor (MC4R) pathway lost a similar amount of weight with tirzepatide as adults without a genetic mutation, according to a speaker.

DALLAS — In this Healio video exclusive, Ania M. Jastreboff, MD, PhD, highlights several medications that may have a large impact on obesity care in the near future.

DALLAS — Adults with overweight or obesity receiving tirzepatide have a decrease in appetite, food craving and other eating behaviors, according to a speaker at ObesityWeek.